Founded in 2015, Zista Pharma, classified under reg no. 09912795 is an active company. Currently registered at Suite # G 19,the Business & Technology Center (btc SG1 2DX, Stevenage the company has been in the business for nine years. Its financial year was closed on Monday 30th December and its latest financial statement was filed on 2021/12/31. Since 2018/11/28 Zista Pharma Limited is no longer carrying the name Eywa Pharma.
The firm has 3 directors, namely Mohammed A., Laith A. and Samie A.. Of them, Mohammed A., Laith A., Samie A. have been with the company the longest, being appointed on 31 January 2024. As of 6 May 2024, there were 5 ex directors - Brijesh K., Senthil P. and others listed below. There were no ex secretaries.
| Office Address | Suite # G 19,the Business & Technology Center (btc |
| Office Address2 | Bessemer Drive |
| Town | Stevenage |
| Post code | SG1 2DX |
| Country of origin | United Kingdom |
| Registration Number | 09912795 |
| Date of Incorporation | Fri, 11th Dec 2015 |
| Industry | Wholesale of pharmaceutical goods |
| End of financial Year | 30th December |
| Company age | 9 years old |
| Account next due date | Fri, 29th Dec 2023 (129 days after) |
| Account last made up date | Fri, 31st Dec 2021 |
| Next confirmation statement due date | Wed, 9th Oct 2024 (2024-10-09) |
| Last confirmation statement dated | Mon, 25th Sep 2023 |
Position: Director
Appointed: 31 January 2024
Position: Director
Appointed: 31 January 2024
Position: Director
Appointed: 31 January 2024
The list of persons with significant control who own or have control over the company consists of 1 name. As we researched, there is Crescent Pharmaceuticals Limited from Basingstoke, England. This PSC is classified as "a private company limited by shares", has 75,01-100% voting rights and has 75,01-100% shares. This PSC has 75,01-100% voting rights and has 75,01-100% shares.
Crescent Pharmaceuticals Limited
Key House Sarum Hill, Basingstoke, RG21 8SR, England
| Legal authority | Companies Act 2006 |
| Legal form | Private Company Limited By Shares |
| Notified on | 31 January 2024 |
| Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
| Eywa Pharma | November 28, 2018 |
| Eywa Pharma Pvt | October 6, 2017 |
| Profit & Loss | |||||||
|---|---|---|---|---|---|---|---|
| Accounts Information Date | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
| Net Worth | 1 | ||||||
| Balance Sheet | |||||||
| Cash Bank On Hand | 230 399 | 20 828 | 23 282 | 59 922 | 5 420 | 5 499 | |
| Current Assets | 240 166 | 2 800 494 | 5 443 204 | 5 856 771 | 4 932 899 | 7 295 781 | |
| Debtors | 9 767 | 2 779 666 | 5 024 070 | 5 450 053 | 4 664 896 | 7 156 110 | |
| Net Assets Liabilities | 641 023 | 7 813 145 | 7 705 645 | 18 348 659 | 17 274 376 | 15 501 469 | |
| Other Debtors | 8 622 | 11 364 | 37 236 | 6 668 | 6 668 | 10 508 | |
| Property Plant Equipment | 7 181 | 6 796 | 3 842 | 943 | 1 052 | 2 240 | |
| Total Inventories | 395 852 | 346 796 | 262 583 | 134 172 | |||
| Net Assets Liabilities Including Pension Asset Liability | 1 | ||||||
| Reserves/Capital | |||||||
| Shareholder Funds | 1 | ||||||
| Other | |||||||
| Accrued Liabilities Deferred Income | 2 500 | 28 731 | 5 006 | 12 250 | 23 000 | 9 788 | |
| Accumulated Amortisation Impairment Intangible Assets | 6 167 | 15 861 | 40 576 | ||||
| Accumulated Depreciation Impairment Property Plant Equipment | 345 | 3 562 | 7 110 | 10 435 | 11 011 | 11 491 | |
| Amounts Owed By Associates Joint Ventures Participating Interests | 4 985 449 | 5 411 913 | 4 361 776 | ||||
| Amounts Owed By Group Undertakings Participating Interests | 2 767 990 | 4 985 449 | 5 411 913 | 4 361 776 | 7 111 638 | ||
| Amounts Owed To Group Undertakings Participating Interests | 2 843 671 | 13 249 389 | 7 300 382 | 14 512 903 | 18 734 547 | ||
| Average Number Employees During Period | 1 | 2 | 3 | 3 | 4 | 4 | |
| Bank Borrowings Overdrafts | 2 530 | ||||||
| Comprehensive Income Expense | -58 978 | -358 008 | -107 500 | -710 147 | -1 074 283 | -1 772 907 | |
| Creditors | 12 644 | 65 758 | 372 956 | 132 486 | 408 866 | 350 029 | |
| Depreciation Rate Used For Property Plant Equipment | 33 | 33 | 33 | 33 | 33 | 33 | |
| Finished Goods | 246 366 | 262 583 | 133 853 | ||||
| Fixed Assets | 414 865 | 7 923 371 | 15 885 516 | 19 924 935 | 27 263 445 | 27 290 689 | |
| Future Minimum Lease Payments Under Non-cancellable Operating Leases | 45 508 | 24 736 | 24 603 | 24 603 | 22 127 | ||
| Income Expense Recognised Directly In Equity | 700 000 | 7 530 130 | 11 353 161 | ||||
| Increase Decrease Due To Transfers Between Classes Intangible Assets | -159 514 | ||||||
| Increase Decrease Through Other Changes Intangible Assets | -57 775 | ||||||
| Increase From Amortisation Charge For Year Intangible Assets | 6 167 | 9 694 | 24 715 | ||||
| Increase From Depreciation Charge For Year Property Plant Equipment | 345 | 3 217 | 3 548 | 3 325 | 576 | 480 | |
| Intangible Assets | 102 806 | 159 514 | 207 923 | 314 717 | 386 400 | 412 456 | |
| Intangible Assets Gross Cost | 102 806 | 159 514 | 207 923 | 320 884 | 402 261 | 453 032 | |
| Investments | 304 878 | 7 757 061 | 15 673 751 | 19 609 275 | 26 875 993 | 26 875 993 | |
| Investments Fixed Assets | 304 878 | 7 757 061 | 15 673 751 | 19 609 275 | 26 875 993 | 26 875 993 | |
| Investments In Group Undertakings Participating Interests | 304 878 | 7 757 061 | 15 673 751 | 19 609 275 | 26 875 993 | 26 875 993 | |
| Issue Equity Instruments | 700 000 | 7 530 130 | 11 353 161 | ||||
| Net Current Assets Liabilities | 227 522 | 2 734 736 | 5 070 248 | 5 724 285 | 4 524 033 | 6 945 752 | |
| Other Creditors | 117 | 3 796 | 20 923 | 4 577 | 19 424 | 2 608 | |
| Other Taxation Social Security Payable | 8 901 | 12 363 | 9 342 | 55 242 | 50 689 | 86 953 | |
| Prepayments Accrued Income | 1 145 | 312 | 1 385 | 2 378 | 7 844 | 6 254 | |
| Profit Loss | -58 978 | -358 008 | -107 500 | -710 147 | -1 074 283 | -1 772 907 | |
| Property Plant Equipment Gross Cost | 7 526 | 10 358 | 10 952 | 11 378 | 12 063 | 13 731 | |
| Provisions For Liabilities Balance Sheet Subtotal | 1 364 | 1 291 | 730 | 179 | 199 | 425 | |
| Total Additions Including From Business Combinations Property Plant Equipment | 594 | 426 | 685 | 1 668 | |||
| Total Assets Less Current Liabilities | 642 387 | 10 658 107 | 20 955 764 | 25 649 220 | 31 787 478 | 34 236 441 | |
| Trade Creditors Trade Payables | 1 126 | 20 868 | 342 691 | 60 417 | 315 753 | 248 150 | |
| Trade Debtors Trade Receivables | 29 094 | 288 608 | 27 710 | ||||
| Called Up Share Capital Not Paid Not Expressed As Current Asset | 1 | ||||||
| Number Shares Allotted | 1 | ||||||
| Par Value Share | 1 | ||||||
| Share Capital Allotted Called Up Paid | 1 | ||||||
| Type | Category | Free download | |
|---|---|---|---|
| MR04 |
Charge 099127950004 satisfaction in full. filed on: 2nd, February 2024 |
mortgage | Free Download (1 page) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy